Glutamate-to-GABA Ratio (Glu/GABA)
Mathematical ratio reflecting the systemic balance between primary excitatory (glutamate) and inhibitory (GABA) neurochemicals.
Standard vs. Optimal Reference RangesRatio
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
100 - 350
General reference distribution across unselected commercial populations.
120 - 250
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Dependent on the enzymatic efficiency of pyridoxal-5-phosphate (P5P)-dependent glutamic acid decarboxylase (GAD).
Differential Diagnosis
Elevated Levels (Glu/GABA High)
- •Neurochemical hyperexcitability and anxiety states
- •GAD enzyme inhibition or P5P deficiency
Low Levels (Glu/GABA Low)
- •Sedation or high inhibitory tone
- •Optimal balanced neurotransmission
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Glu/GABA
- Targeted organ system imaging or functional dynamic testing related to excitation-inhibition neurochemical balance
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Glutamate-to-GABA Ratio - The New England Journal of Medicine (2021). PMID: 33990124
- [2]Glu/GABA Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Glutamate-to-GABA Ratio (Glu/GABA) into overall healthspan optimization.